Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience. [electronic resource]
Producer: 20181016Description: 518-526 p. digitalISSN:- 0929-6646
- 2-Naphthylamine
- Aged
- Alanine Transaminase -- blood
- Anilides -- adverse effects
- Antiviral Agents -- adverse effects
- Carbamates -- adverse effects
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Liver Cirrhosis -- physiopathology
- Liver Transplantation
- Macrocyclic Compounds -- adverse effects
- Male
- Middle Aged
- Postoperative Period
- Proline -- analogs & derivatives
- Ribavirin -- adverse effects
- Ritonavir -- adverse effects
- Sulfonamides -- adverse effects
- Sustained Virologic Response
- Uracil -- adverse effects
- Valine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.